Capital Fund Management S.A. Galapagos Nv Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$68.86 - $83.34 $1.32 Million - $1.6 Million	-19,223 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$76.15 - $111.94 $1.46 Million - $2.15 Million	19,223 New	19,223 $1.48 Million
Q2 2020 Aug 13, 2020	SELL	$185.52 - $231.25 $565,093 - $704,387	-3,046 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$143.0 - $274.03 $435,578 - $834,695	3,046 New	3,046 $596,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.8B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.